Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction

Molecular Neurodegeneration

Volumn 6, Issue 1, 2011, Pages

  Abdul Muneer, P M ^a   Alikunju, Saleena ^a   Szlachetka, Adam M ^a   Murrin, L Charles ^a   Haorah, James ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOCHALASIN B; GLUCOSE; GLUCOSE TRANSPORTER 1; LEVACECARNINE; METHAMPHETAMINE; OCCLUDIN; PROTEIN ZO1;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BLOOD BRAIN BARRIER; BRAIN ENDOTHELIUM; BRAIN TISSUE; CELL SURVIVAL; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRIC RESISTANCE; ENDOTHELIUM; ENDOTHELIUM CELL; ENERGY; FRONTAL CORTEX; GENETIC TRANSCRIPTION; GLUCOSE BRAIN LEVEL; GLUCOSE TRANSPORT; GLUCOSE UTILIZATION; HUMAN; HUMAN CELL; MALE; MICROVASCULATURE; MONOLAYER CULTURE; MOUSE; NONHUMAN; OCCIPITAL CORTEX; PERMEABILITY; PROTEIN EXPRESSION; REGULATORY MECHANISM;

ANIMALIA;

EID: 79953092806     PISSN: None     EISSN: 17501326     Source Type: Journal    
DOI: 10.1186/1750-1326-6-23     Document Type: Article

References (50)

1. Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge. R Kuczenski DS Segal WP Melega G Lacan SJ McCunney, Neuropsychopharmacology 2009 34 11 2430 2441 10.1038/npp.2009.73 19571794
2. Methamphetamine use in rural Midwesterners. KM Grant SS Kelley S Agrawal JL Meza JR Meyer DJ Romberger, Am J Addict 2007 16 2 79 84 10.1080/ 10550490601184159 17453608 (Pubitemid 46633927)
3. Dopamine-induced behavioral changes and oxidative stress in methamphetamine-induced neurotoxicity. T Kita I Miyazaki M Asanuma M Takeshima GC Wagner, Int Rev Neurobiol 2009 88 43 64 full-text 19897074
4. Office of applied studies. Results from the 2005 National Survey on Drug Use and Health: National findings. SAMHSA, DHHS Publication No. SMA 05-4062, NSDUH Series H-28: Substance Abuse and Mental Health Services Administration 2006
5. Neurocognitive effects of methamphetamine: a critical review and meta-analysis. JC Scott SP Woods GE Matt RA Meyer RK Heaton JH Atkinson I Grant, Neuropsychol Rev 2007 17 3 275 297 10.1007/s11065-007-9031-0 17694436 (Pubitemid 47498174)
6. Methamphetamine toxicity and messengers of death. IN Krasnova JL Cadet, Brain Res Rev 2009 60 2 379 407 10.1016/j.brainresrev.2009.03.002 19328213
7. Effect of temperature on dopamine transporter function and intracellular accumulation of methamphetamine: implications for methamphetamine-induced dopaminergic neurotoxicity. T Xie UD McCann S Kim J Yuan GA Ricaurte, J Neurosci 2000 20 20 7838 7845 11027249
8. The effects of methamphetamine on core body temperature in the rat - part 2: an escalating regimen. BJ Myles KE Sabol, Psychopharmacology (Berl) 2008 198 3 313 322 10.1007/s00213-007-1060-0 18438647
9. Methamphetamine causes microglial activation in the brains of human abusers. Y Sekine Y Ouchi G Sugihara N Takei E Yoshikawa K Nakamura Y Iwata KJ Tsuchiya S Suda K Suzuki,, et al. J Neurosci 2008 28 22 5756 5761 10.1523/JNEUROSCI.1179-08.2008 18509037
10. Methamphetamine-induced neurotoxicity and microglial activation are not mediated by fractalkine receptor signaling. DM Thomas DM Francescutti-Verbeem DM Kuhn, J Neurochem 2008 106 2 696 705 10.1111/j.1471-4159.2008.05421.x 18410508
11. Selective Vulnerability in Striosomes and in the Nigrostriatal Dopaminergic Pathway After Methamphetamine Administration: Early Loss of TH in Striosomes After Methamphetamine. N Granado S Ares-Santos E O'Shea C Vicario-Abejon MI Colado R Moratalla, Neurotox Res 2009 18 1 48 58 10.1007/s12640-009-9106-1 19760475
12. Chronic amphetamine intoxication and the blood-brain barrier permeability to inert polar molecules studied in the vascularly perfused guinea pig brain. LM Rakic BV Zlokovic H Davson MB Segal DJ Begley MN Lipovac DM Mitrovic, J Neurol Sci 1989 94 1-3 41 50 10.1016/0022-510X(89)90216-5 2515257 (Pubitemid 20019443)
13. Speed kills: cellular and molecular bases of methamphetamine-induced nerve terminal degeneration and neuronal apoptosis. JL Cadet S Jayanthi X Deng, FASEB J 2003 17 13 1775 1788 10.1096/fj.03-0073rev 14519657 (Pubitemid 37214772)
14. Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. C Davidson AJ Gow TH Lee EH Ellinwood, Brain Res Brain Res Rev 2001 36 1 1 22 11516769 (Pubitemid 32763126)
15. Methamphetamine-induced TNF-alpha gene expression and activation of AP-1 in discrete regions of mouse brain: potential role of reactive oxygen intermediates and lipid peroxidation. G Flora YW Lee A Nath W Maragos B Hennig M Toborek, Neuromolecular Med 2002 2 1 71 85 10.1385/NMM:2:1:71 12230306 (Pubitemid 37012511)
16. Methamphetamine-induced early increase of IL-6 and TNF-alpha mRNA expression in the mouse brain. J Goncalves T Martins R Ferreira N Milhazes F Borges CF Ribeiro JO Malva TR Macedo AP Silva, Ann N Y Acad Sci 2008 1139 103 111 10.1196/annals.1432.043 18991854
17. A comparison of echocardiographic findings in young adults with cardiomyopathy: with and without a history of methamphetamine abuse. H Ito KK Yeo M Wijetunga TB Seto K Tay IJ Schatz, Clin Cardiol 2009 32 6 18 22 10.1002/clc.20367 19330818
18. Self-vaccination by methamphetamine glycation products chemically links chronic drug abuse and cardiovascular disease. J Treweek S Wee GF Koob TJ Dickerson KD Janda, Proc Natl Acad Sci USA 2007 104 28 11580 11584 10.1073/pnas.0701328104 17592122 (Pubitemid 47175055)
19. Methamphetamine directly accelerates beating rate in cardiomyocytes by increasing Ca(2+) entry via L-type Ca(2+) channel. K Sugimoto K Okamura H Tanaka S Takashima H Ochi T Yamamoto R Matoba, Biochem Biophys Res Commun 2009 390 4 1214 1220 10.1016/j.bbrc.2009.10.124 19878660
20. Acute methamphetamine intoxication brain hyperthermia, blood-brain barrier, brain edema, and morphological cell abnormalities. EA Kiyatkin HS Sharma, Int Rev Neurobiol 2009 88 65 100 full-text 19897075
21. Acute administration of 3,4-methylenedioxymethamphetamine induces profound hyperthermia, blood-brain barrier disruption, brain edema formation, and cell injury. HS Sharma SF Ali, Ann N Y Acad Sci 2008 1139 242 258 10.1196/annals.1432.052 18991870
22. Nanowired-drug delivery enhances neuroprotective efficacy of compounds and reduces spinal cord edema formation and improves functional outcome following spinal cord injury in the rat. HS Sharma SF Ali ZR Tian R Patnaik S Patnaik A Sharma A Boman P Lek E Seifert T Lundstedt, Acta Neurochir Suppl 2010 106 343 350 full-text 19812975
23. Methamphetamine disrupts blood-brain barrier function by induction of oxidative stress in brain endothelial cells. SH Ramirez R Potula S Fan T Eidem A Papugani N Reichenbach H Dykstra BB Weksler IA Romero PO Couraud,, et al. J Cereb Blood Flow Metab 2009 29 12 1933 1945 10.1038/jcbfm.2009.112 19654589
24. Glucose transporter proteins in brain. F Maher SJ Vannucci IA Simpson, FASEB J 1994 8 13 1003 1011 7926364 (Pubitemid 24338544)
25. Enhancement of glucose transporter expression of brain endothelial cells by vascular endothelial growth factor derived from glioma exposed to hypoxia. WL Yeh CJ Lin WM Fu, Mol Pharmacol 2008 73 1 170 177 10.1124/mol.107.038851 17942749
26. The facilitative glucose transporter GLUT3: 20 years of distinction. IA Simpson D Dwyer D Malide KH Moley A Travis SJ Vannucci, Am J Physiol Endocrinol Metab 2008 295 2 242 253 10.1152/ajpendo.90388.2008 18577699
27. Supply and demand in cerebral energy metabolism: the role of nutrient transporters. IA Simpson A Carruthers SJ Vannucci, J Cereb Blood Flow Metab 2007 27 11 1766 1791 10.1038/sj.jcbfm.9600521 17579656 (Pubitemid 47624552)
28. Acetyl-L-carnitine shows neuroprotective and neurotrophic activity in primary culture of rat embryo motoneurons. P Bigini S Larini C Pasquali V Muzio T Mennini, Neurosci Lett 2002 329 3 334 338 10.1016/S0304-3940(02)00667-5 12183043 (Pubitemid 35245354)
29. Acetyl-L-carnitine fed to old rats partially restores mitochondrial function and ambulatory activity. TM Hagen RT Ingersoll CM Wehr J Lykkesfeldt V Vinarsky JC Bartholomew MH Song BN Ames, Proc Natl Acad Sci USA 1998 95 16 9562 9566 10.1073/pnas.95.16.9562 9689120 (Pubitemid 28506271)
30. Methamphetamine use: Lessons learned. D Hunt S Kuck L Truitt, Document No. 209730: California department of alcohol and drug programs 2006
31. Methamphetamine blood concentrations in human abusers: application to pharmacokinetic modeling. WP Melega AK Cho D Harvey G Lacan, Synapse 2007 61 4 216 220 10.1002/syn.20365 17230548
32. Toxicokinetics of amphetamines: metabolism and toxicokinetic data of designer drugs, amphetamine, methamphetamine, and their N-alkyl derivatives. T Kraemer HH Maurer, Ther Drug Monit 2002 24 2 277 289 10.1097/00007691-200204000- 00009 11897973 (Pubitemid 34248035)
33. Oxidation of methamphetamine and methylenedioxymethamphetamine by CYP2D6. LY Lin EW Di Stefano DA Schmitz L Hsu SW Ellis MS Lennard GT Tucker AK Cho, Drug Metab Dispos 1997 25 9 1059 1064 9311621 (Pubitemid 27396493)
34. N-glycosylation of glucose transporter-1 (Glut-1) is associated with increased transporter affinity for glucose in human leukemic cells. N Ahmed MV Berridge, Leuk Res 1999 23 4 395 401 10.1016/S0145-2126(98)00179-9 10229326 (Pubitemid 29166774)
35. Brain region-specific neurodegenerative profiles showing the relative importance of amphetamine dose, hyperthermia, seizures, and the blood-brain barrier. JF Bowyer M Thomas LC Schmued SF Ali, Ann N Y Acad Sci 2008 1139 127 139 10.1196/annals.1432.005 18991857
36. Rapid morphological brain abnormalities during acute methamphetamine intoxication in the rat: an experimental study using light and electron microscopy. HS Sharma EA Kiyatkin, J Chem Neuroanat 2009 37 1 18 32 10.1016/j.jchemneu.2008.08.002 18773954
37. Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: Implication for HIV-1 neuropathogenesis in the context of drug abuse. SD Mahajan R Aalinkeel DE Sykes JL Reynolds B Bindukumar A Adal M Qi J Toh G Xu PN Prasad,, et al. Brain Res 2008 1203 133 148 10.1016/j.brainres.2008.01.093 18329007
38. The blood-brain barrier: geriatric relevance of a critical brain-body interface. N Zeevi J Pachter LD McCullough L Wolfson GA Kuchel, J Am Geriatr Soc 2010 58 9 1749 1757 10.1111/j.1532-5415.2010.03011.x 20863334
39. Brain fuel metabolism, aging, and Alzheimer's disease. S Cunnane S Nugent M Roy A Courchesne-Loyer E Croteau S Tremblay A Castellano F Pifferi C Bocti N Paquet,, et al. Nutrition 2011 27 1 3 20 10.1016/j.nut.2010.07.021 21035308
40. T295M-associated Glut1 deficiency syndrome with normal erythrocyte 3-OMG uptake. T Fujii M Morimoto H Yoshioka YY Ho PP Law D Wang DC De Vivo, Brain Dev 2010 33 4 316 20 10.1016/j.braindev.2010.06.012 20630673
41. Uncovering microdeletions in patients with severe Glut-1 deficiency syndrome using SNP oligonucleotide microarray analysis. B Levy D Wang PM Ullner K Engelstad H Yang O Nahum WK Chung DC De Vivo, Mol Genet Metab 2010 100 2 129 135 10.1016/j.ymgme.2010.03.007 20382060
42. Differential glycosylation of the GLUT1 glucose transporter in brain capillaries and choroid plexus. AK Kumagai KJ Dwyer WM Pardridge, Biochim Biophys Acta 1994 1193 1 24 30 10.1016/0005-2736(94)90328-X 8038191 (Pubitemid 24234174)
43. The transport of sugars across the perfused choroid plexus of the sheep. R Deane MB Segal, J Physiol 1985 362 245 260 4020688 (Pubitemid 15122245)
44. Frontal glucose hypometabolism in abstinent methamphetamine users. SJ Kim IK Lyoo J Hwang YH Sung HY Lee DS Lee DU Jeong PF Renshaw, Neuropsychopharmacology 2005 30 7 1383 1391 15726115 (Pubitemid 40848092)
45. Higher cortical and lower subcortical metabolism in detoxified methamphetamine abusers. ND Volkow L Chang GJ Wang JS Fowler D Franceschi MJ Sedler SJ Gatley R Hitzemann YS Ding C Wong,, et al. Am J Psychiatry 2001 158 3 383 389 10.1176/appi.ajp.158.3.383 11229978 (Pubitemid 32205194)
46. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. ED London SL Simon SM Berman MA Mandelkern AM Lichtman J Bramen AK Shinn K Miotto J Learn Y Dong,, et al. Arch Gen Psychiatry 2004 61 1 73 84 10.1001/archpsyc.61.1.73 14706946 (Pubitemid 38044643)
47. Effects of repeated high-dose methamphetamine on local cerebral glucose utilization in rats. YH Huang SJ Tsai TW Su CB Sim, Neuropsychopharmacology 1999 21 3 427 434 10.1016/S0893-133X(99)00029-9 10457540
48. Alcohol-induced blood-brain barrier dysfunction is mediated via inositol 1,4,5-triphosphate receptor (IP3R)-gated intracellular calcium release. J Haorah B Knipe S Gorantla J Zheng Y Persidsky, J Neurochem 2007 100 2 324 336 10.1111/j.1471-4159.2006.04245.x 17241155 (Pubitemid 46010994)
49. Hexose uptake in primary cultures of bovine brain microvessel endothelial cells. II. Effects of conditioned media from astroglial and glioma cells. Y Takakura AM Trammel SL Kuentzel TJ Raub A Davies SA Baldwin RT Borchardt, Biochim Biophys Acta 1991 1070 1 11 19 10.1016/0005-2736(91)90140-4 1751516
50. Fluorescence imaging of blood-brain barrier disruption. BT Hawkins RD Egleton, J Neurosci Methods 2006 151 2 262 267 10.1016/j.jneumeth.2005.08.006 16181683 (Pubitemid 43294448)